2019
DOI: 10.1016/j.amjcard.2019.07.009
|View full text |Cite
|
Sign up to set email alerts
|

Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Rheumatoid Arthritis (from the Nationwide Inpatient Database)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0
3

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 16 publications
0
9
0
3
Order By: Relevance
“…In their cohort of 2557 patients, 75.6% had RA [ 7 ]. In a report by Elbadawi et al, in-hospital mortality was studied after TAVR and SAVR in patients with RA, finding no difference between the two treatment options [ 8 ]. To our knowledge, our report was the first study investigating the long-term outcomes of RA patients treated with SAVR for aortic valve stenosis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In their cohort of 2557 patients, 75.6% had RA [ 7 ]. In a report by Elbadawi et al, in-hospital mortality was studied after TAVR and SAVR in patients with RA, finding no difference between the two treatment options [ 8 ]. To our knowledge, our report was the first study investigating the long-term outcomes of RA patients treated with SAVR for aortic valve stenosis.…”
Section: Discussionmentioning
confidence: 99%
“…However, there is currently very limited evidence regarding RA patients treated with valvular surgery and especially with aortic valve stenosis. Previous studies have indicated that RA does not increase in-hospital mortality after transapical (TAVR) or surgical aortic valve replacement (SAVR) [ 7 , 8 ], but there are no studies about the long-term results of these procedures on RA patients. Therefore, we investigated the outcomes of SAVR for aortic valve stenosis in patients with RA.…”
Section: Introductionmentioning
confidence: 99%
“…Las manifestaciones cardiovasculares son una de las principales causas de mortalidad y morbilidad extraarticular en la AR (6). Cualquier parte del corazón puede ser afectada por la inflamación autoinmunitaria; las características usuales incluyen pericarditis, miocarditis, arteritis, endocarditis crónica y enfermedad valvular.…”
Section: Discussionunclassified
“…Furthermore, data derived from a large nationwide registry demostrated that TAVI was also associated with favorable outcomes in patients with autoimmune connective tissue diseases and is comparable with AVR in terms of in‐hospital mortality in this population (Table 1). 7,8 …”
Section: Discussionmentioning
confidence: 99%
“…Due to the lower risk of PVL, TAVI procedure offers for these patients immediate short‐term improvements in survival potentially, but also longer‐term benefits such as a reduction in the rate of rehospitalizations for acute heart failure or anemia 8 …”
Section: Discussionmentioning
confidence: 99%